John D Seeger (John Seeger)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Epstein Barr Virus

Diffuse Large B Cell Lymphoma

Top Venues

Pharmacoepidemiology and drug safety

Postgraduate medicine

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Vicki Osborne, Amie J Goodin, Joshua Brown, Almut G Winterstein, Andrew Bate, Catherine Cohet, Lisa G Pont, David Moeny, Olaf Klungel, Simone Pinheiro, John D Seeger, K Arnold Chan, Stanley Edlavitch, Hugh Tilson, Deborah Layton
Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and drug safety 33 (4) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Correction to: Development and Validation of ICD‑10‑CM‑based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety (2023)
Andrea K Chomistek, Kelesitse Phiri, Michael C Doherty, Jenna F Calderbank, Stephanie E Chiuve, Brenda Hinman McIlroy, Michael C Snabes, Cheryl Enger, John D Seeger
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes. Drug safety 46 (2) (2023)
Monica L Bertoia, Kelesitse Phiri, C Robin Clifford, Michael Doherty, Li Zhou, Laura T Wang, Natalie A Bertoia, Florence T Wang, John D Seeger
Identification of pregnancies and infants within a US commercial healthcare administrative claims database. Pharmacoepidemiology and drug safety 31 (8) (2022)
Sigal Kaplan, Monica L Bertoia, Amir Lass, Florence T Wang, Alison Evans, Sandeep Dhanda, Debabrata Roy, John D Seeger
Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study. Pharmacoepidemiology and drug safety (2022)
William M Spalding, Monica L Bertoia, Cynthia M Bulik, John D Seeger
Treatment characteristics among patients with binge-eating disorder: an electronic health records analysis. Postgraduate medicine (2022)
Veena Hoffman, Nina Sahlertz Kristiansen, Marie Linder, Andrea V Margulis, Brandon T Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susanna Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger, null null
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug safety 44 (8) (2021)
John D Seeger, Anthony P Nunes, Anita M Loughlin
Using RWE research to extend clinical trials in diabetes: An example with implications for the future. Diabetes, obesity & metabolism (2021)
John D Seeger, Kourtney J Davis, Michelle R Iannacone, Wei Zhou, Nancy Dreyer, Almut G Winterstein, Nancy Santanello, Barry Gertz, Jesse A Berlin
Methods for external control groups for single arm trials or long-term uncontrolled extensions to randomized clinical trials. Pharmacoepidemiology and drug safety 29 (11) (2020)